search
Back to results

Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH) (REBIRTH)

Primary Purpose

Liver Resection, Cancer

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Radiofrequency assisted liver partition with portal vein ligation (RALPP)
Portal vein embolization (PVE)
Sponsored by
Imperial College London
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Liver Resection focused on measuring Liver hypertrophy, Liver resection, Liver metastases, Portal vein ligation, Portal vein embolization, Radiofrequency splitting

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥ 18 years
  • Any patient requiring right or extended right hepatectomy with FLRV less than 25% on preoperative volumetric study
  • WHO performance status 0, 1 or 2
  • Patient able to comply with protocol requirements and deemed fit for surgical resection
  • Written informed consent

Exclusion Criteria:

  • Inability to give informed consent
  • Pregnancy
  • WHO status 3 or 4
  • New York Heart Association Classification Grade III or IV

Sites / Locations

  • Hammersmith Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Portal vein embolization (PVE)

Radiofrequency assisted liver partition and ligation (RALPP)

Arm Description

Patients allocated to the PVE group will receive pre-intervention blood tests and a contrast enhanced CT scan of the abdomen. They will then have their portal vein embolized radiologically once their pre-intervention investigations have been completed and reviewed by the clinical team. Post-intervention investigations (blood tests and CT scan) will take place 4 weeks after the completion of the PVE. At this point, they will be listed to receive their definitive surgical hepatectomy.

Patients allocated to the RALPP group will receive pre-intervention blood tests and a contrast enhanced CT scan of the abdomen. They will then have their right portal vein surgically ligated followed by radiofrequency ablation in situ splitting of the liver. Certain patients may additionally have a tumourectomy or wedge resection of the left liver lobe if clinically indicated. The RALPP procedure will occur once the patient's pre-intervention investigations have been completed and reviewed by the clinical team. Post-intervention investigations (blood tests and CT scan) will take place 2 weeks after the completion of the RALPP. At this point, they will be listed to receive their definitive surgical hepatectomy.

Outcomes

Primary Outcome Measures

Changes in Liver Remnant Volume
Percentage change in remnant liver volume following intervention. This will be measured by volumetric analysis of CT scan. Positive number represents increases and negative number represents decreases.

Secondary Outcome Measures

Postoperative Liver Function Tests
Blood tests
Number of Participants With Postoperative Complications (Dindo Clavien ≥Grade 3b)
As defined by Dindo Clavien classification of surgical complications (≥grade 3b).

Full Information

First Posted
August 5, 2014
Last Updated
October 18, 2019
Sponsor
Imperial College London
search

1. Study Identification

Unique Protocol Identification Number
NCT02216773
Brief Title
Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH)
Acronym
REBIRTH
Official Title
Liver Regeneration: a Single-centre, Prospective, Randomised Controlled Trial Comparing Radiofrequency Assisted Liver Partition With Portal Vein Ligation (RALPP) With Portal Vein Embolization (PVE) for Preoperative Induction of Liver Hypertrophy in Patients With Insufficient Future Liver Remnant Volume for Major Liver Resection.
Study Type
Interventional

2. Study Status

Record Verification Date
October 2019
Overall Recruitment Status
Completed
Study Start Date
July 2015 (Actual)
Primary Completion Date
April 2018 (Actual)
Study Completion Date
April 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Imperial College London

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to compare two different techniques (portal vein embolization and radiofrequency assisted liver partition with portal vein ligation) for increasing liver volume prior to major liver resection.
Detailed Description
Liver resection remains the gold standard treatment for patients with liver tumours providing them the only chance for long-term survival. In up to 45% of cases that are amenable to surgical resection, an extended hepatectomy (removal of part of the liver) is usually necessary to achieve a clear resection margin. However, there must be enough liver left behind to meet the demands of the body. Indeed, liver failure due to insufficient remnant liver volume is still the principal cause of postoperative death following a major liver resection. The liver receives its main blood supply from two vessels (the portal vein and the hepatic artery). In order to decrease the complications and improve the safety of extensive liver surgery in patients with insufficient future liver remnant volume (FLRV), pre-operative embolization (i.e. blockage) of part of the portal vein can be undertaken. This has the effect of inducing growth of the liver on the unaffected side. Thus, when the resection is carried out, an increased FLRV (of around 12%) reduces post-operative liver failure. An alternative technique is to perform surgical ligation of the portal vein along with splitting of the liver. The diseased portion of liver is left in the body for 7-10 days while the healthy side is induced to grow. During this time, the diseased portion continues to support the body's requirement for liver function and reduces the risk of liver failure. FLRV has been shown to increase by around 74% with this technique. However, there are more postoperative complications with the alternative technique such as bile leaks. The aim of this study is to test a new way of splitting the liver so that the increased FLRV can be achieved without the increased complication rate.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Liver Resection, Cancer
Keywords
Liver hypertrophy, Liver resection, Liver metastases, Portal vein ligation, Portal vein embolization, Radiofrequency splitting

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
57 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Portal vein embolization (PVE)
Arm Type
Active Comparator
Arm Description
Patients allocated to the PVE group will receive pre-intervention blood tests and a contrast enhanced CT scan of the abdomen. They will then have their portal vein embolized radiologically once their pre-intervention investigations have been completed and reviewed by the clinical team. Post-intervention investigations (blood tests and CT scan) will take place 4 weeks after the completion of the PVE. At this point, they will be listed to receive their definitive surgical hepatectomy.
Arm Title
Radiofrequency assisted liver partition and ligation (RALPP)
Arm Type
Experimental
Arm Description
Patients allocated to the RALPP group will receive pre-intervention blood tests and a contrast enhanced CT scan of the abdomen. They will then have their right portal vein surgically ligated followed by radiofrequency ablation in situ splitting of the liver. Certain patients may additionally have a tumourectomy or wedge resection of the left liver lobe if clinically indicated. The RALPP procedure will occur once the patient's pre-intervention investigations have been completed and reviewed by the clinical team. Post-intervention investigations (blood tests and CT scan) will take place 2 weeks after the completion of the RALPP. At this point, they will be listed to receive their definitive surgical hepatectomy.
Intervention Type
Procedure
Intervention Name(s)
Radiofrequency assisted liver partition with portal vein ligation (RALPP)
Intervention Type
Procedure
Intervention Name(s)
Portal vein embolization (PVE)
Primary Outcome Measure Information:
Title
Changes in Liver Remnant Volume
Description
Percentage change in remnant liver volume following intervention. This will be measured by volumetric analysis of CT scan. Positive number represents increases and negative number represents decreases.
Time Frame
2 or 4 weeks post intervention (2 weeks post RALPP; 4 weeks post PVE)
Secondary Outcome Measure Information:
Title
Postoperative Liver Function Tests
Description
Blood tests
Time Frame
Postoperatively (daily until discharge; then at clinic appointments up to 18 months from randomization)
Title
Number of Participants With Postoperative Complications (Dindo Clavien ≥Grade 3b)
Description
As defined by Dindo Clavien classification of surgical complications (≥grade 3b).
Time Frame
Up to hospital discharge (estimated to be between 2 and 10 days)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years Any patient requiring right or extended right hepatectomy with FLRV less than 25% on preoperative volumetric study WHO performance status 0, 1 or 2 Patient able to comply with protocol requirements and deemed fit for surgical resection Written informed consent Exclusion Criteria: Inability to give informed consent Pregnancy WHO status 3 or 4 New York Heart Association Classification Grade III or IV
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Long R Jiao, MD, FRCS
Organizational Affiliation
Imperial College London
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hammersmith Hospital
City
London
ZIP/Postal Code
W12 0HS
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
24670841
Citation
Gall TM, Sodergren MH, Frampton AE, Fan R, Spalding DR, Habib NA, Pai M, Jackson JE, Tait P, Jiao LR. Radio-frequency-assisted Liver Partition with Portal vein ligation (RALPP) for liver regeneration. Ann Surg. 2015 Feb;261(2):e45-6. doi: 10.1097/SLA.0000000000000607. No abstract available.
Results Reference
background

Learn more about this trial

Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH)

We'll reach out to this number within 24 hrs